EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Effects of a Four‐Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical Trial

Valentina Leta iD, Pavlos Zinzalias, Lucia Batzu iD, Gargi Mandal, Juliet Staunton, Frida Jernstedt, Kristina Rosqvist iD, Jonathan Timpka iD, Trinette van Vliet, Dhaval Trivedi, Aleksandra Podlewska, Miriam Parry und 19 weitere

Movement Disorders · 2025-12 · 40 (12) · 2710-2721

DOI: 10.1002/mds.70047 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Movement Disorders, online erschienen am 23.10.2025. Verfasst von Valentina Leta und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic and Clinical Neuroscience, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom. Hauptthemen laut MEDLINE: Probiotics, Parkinson Disease, Gastrointestinal Microbiome, Inflammation. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Parkinson Academy, Faculty of Medicine at Lund University (Multipark), Skåne Health Care Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gut dysbiosis and gut‐brain‐axis involvement in people with Parkinson's disease ( PwP ) support the use of gut‐microbiota‐modulating interventions. Probiotics may help manage constipation in PwP ; however, mechanisms underpinning additional beneficial properties are unknown.

Objective

The aim was evaluating the effects of a probiotic ( Lacticaseibacillus rhamnosus, Lactobacillus acidophilus, Lactiplantibacillus plantarum and Enterococcus faecium) on gut microbiota, inflammation, motor and non‐motor symptoms (NMS) in PwP and constipation.

Methods

In this multicenter, randomized, double‐blind, placebo‐controlled trial (NCT05146921), PwP and constipation were randomized (1:1) to receive either the probiotic (4.08 × 10 8 CFU/mL) or placebo orally (70 mL/day) for 12 weeks. The primary endpoint was the differential abundance of gut microbiota taxa between baseline and end‐of‐treatment in the active versus placebo group. Secondary/exploratory endpoints included changes in inflammatory cytokines plasma levels, short‐chain fatty acids (SCFAs) plasma and fecal levels, motor and NMS outcomes after 12 weeks. A per‐protocol analysis was performed.

Results

Between July 17, 2019 and February 6, 2022, 74 participants were randomized. Data from 35 (probiotic) and 33 (placebo) participants were analyzed. Enrichments of bacteria with beneficial health‐related properties ( Odoribacteraceae , Enterococcaceae , and Blautia faecicola ) were observed in the active group compared to placebo ( P ≤ 0.05). Proinflammatory cytokine TNF‐α plasma levels decreased with probiotic treatment and increased with placebo ( P < 0.05). No changes in SCFAs levels were observed. Reductions in time‐to‐ on and NMS scale scores ( P < 0.05) were observed only in the active group.

Conclusions

This probiotic was effective in beneficially enriching the gut microbiota with potential to reduce systemic inflammation, shortening time‐to‐ on following levodopa administration, and alleviating NMS burden in PwP experiencing constipation. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsParkinson DiseaseGastrointestinal MicrobiomeInflammationConstipationHumansMaleFemaleDouble-Blind MethodAgedMiddle AgedDysbiosis

Stichwörter der Autor:innen

Parkinson's diseasegut microbiotainflammationmotor symptomsnon‐motor symptomsprobiotics

Autor:innen und Institutionen

  • Department of Basic and Clinical Neuroscience, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.
  • Parkinson's Foundation Center of Excellence at King's College Hospital, London, United Kingdom.
  • Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milan, Italy.
  • Psychology and Neuroscience, Department of Psychological Medicine, Institute of Psychiatry, King's College London, London, United Kingdom.
  • Department of Neurology, Rehabilitation Medicine, Memory and Geriatrics, Skåne University Hospital, Lund, Sweden.
  • Division of Neurology, Department of Clinical Sciences, Lund University, Lund, Sweden.

ORCID-Profile: Valentina Leta, Lucia Batzu, Kristina Rosqvist, Jonathan Timpka, Daniel J van Wamelen, David Vauzour, Carmen Rodriguez Blazquez

Förderung

  • Swedish Parkinson Academy
  • Faculty of Medicine at Lund University (Multipark)
  • Skåne Health Care Region
  • Swedish Parkinson Foundation
  • Swedish Research Council
  • Symprove Ltd
  • NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London
  • Parkinson's UK

Zitieren

APA

Leta, V., Zinzalias, P., Batzu, L., Mandal, G., Staunton, J., Jernstedt, F., Rosqvist, K., Timpka, J., van Vliet, T., Trivedi, D., Podlewska, A., Parry, M., van Wamelen, D. J., Rizos, A., Sportelli, C., Bonder, A. L., Chung-Faye, G., Falup-Pecurariu, C., Gaisford, S., …, & Ray Chaudhuri, K. (2025). Effects of a Four‐Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical Trial. Movement Disorders, 40(12), 2710-2721. https://doi.org/10.1002/mds.70047

Vancouver

Leta V, Zinzalias P, Batzu L, Mandal G, Staunton J, Jernstedt F, et al. Effects of a Four‐Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical Trial. Movement Disorders. 2025;40(12):2710-2721. doi:10.1002/mds.70047

BibTeX
@article{Leta2025,
  author = {Leta, Valentina and Zinzalias, Pavlos and Batzu, Lucia and Mandal, Gargi and Staunton, Juliet and Jernstedt, Frida and Rosqvist, Kristina and Timpka, Jonathan and van Vliet, Trinette and Trivedi, Dhaval and Podlewska, Aleksandra and Parry, Miriam and van Wamelen, Daniel J and Rizos, Alexandra and Sportelli, Carolina and Bonder, Ana Laura and Chung-Faye, Guy and Falup-Pecurariu, Cristian and Gaisford, Simon and Moretto, Edoardo and Le Gall, Gwenaelle and Vauzour, David and Rodriguez-Mateos, Ana and Sauerbier, Anna and Rodriguez Blazquez, Carmen and Ghyselinck, Jonas and Marsaux, Benoît and Pariante, Carmine Maria and Borsini, Alessandra and Odin, Per and Ray Chaudhuri, Kallol},
  title = {Effects of a Four‐Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical Trial},
  journal = {Movement Disorders},
  year = {2025},
  volume = {40},
  number = {12},
  pages = {2710--2721},
  doi = {10.1002/mds.70047}
}
Kostenlos starten →